{
  "id": 188805,
  "title": "India’s cancer focus must shift to early detection",
  "url": "https://urgent.news/2026/08/05/indias-cancer-focus-must-shift-to-early-detection",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-05T19:31:01.000Z",
  "source": {
    "name": "The Hindu Health",
    "slug": "the-hindu-health",
    "url": "https://www.thehindu.com/opinion/op-ed/indias-cancer-focus-must-shift-to-early-detection/article71310859.ece"
  },
  "original_language": "en",
  "account": "Every day, oncology clinics across India face the unfortunate reality that over 70% of cancer patients are already at an advanced stage when they seek treatment. This often leads to more complex and expensive therapies, with a lower likelihood of achieving a cure. Despite significant investments in advanced tertiary cancer centers and sophisticated treatments, these improvements remain limited because most patients arrive too late. Cancer in India is predominantly diagnosed when symptoms become severe enough to disrupt daily life, often resulting in lost opportunities for curative treatment. The consequences of late diagnosis extend beyond health, affecting poverty, as more than three-quarters of cancer-affected households experience catastrophic healthcare expenses. The survival rate for lung cancer in India is only about 4% within five years, compared to nearly 33% in Japan, highlighting a significant gap in outcomes that can be attributed to late diagnosis across various common cancers. As India's population grows and lifestyles change, the number of new cancer cases is estimated at 1.56 million annually, with over 874,000 deaths in 2024. Approximately 11% of the population has a lifetime risk of developing cancer, rising to over 20% in some northeastern states. The rising burden of cancer necessitates a fundamental shift in national strategy. Prevention must be recognized as a lifelong public health priority rather than occasional awareness campaigns. Nearly half of all cancers are preventable, yet efforts to promote awareness among adults have been ineffective due to ingrained lifestyle habits formed during early life. Therefore, health education must start in schools, where “life skills” should be given the same importance as core subjects like mathematics or social sciences. This education should cover physical, mental, and social health, addiction, diet, vaccinations, financial literacy, and responsibilities towards family, society, and nation. The second crucial step is the need for earlier cancer diagnoses. Public awareness that persistent symptoms lasting more than three weeks warrant medical evaluation can help reduce diagnostic delays. However, awareness alone is not enough; screening remains the most powerful tool for detecting cancer before symptoms appear. While organized screening has been limited to cervical, breast, and prostate cancers, recent scientific advances now enable broader screening possibilities. Blood-based Multi-Cancer Early Detection (MCED) tests can identify multiple malignancies through a single blood sample, including colorectal, lung, liver, pancreatic, ovarian, gastric, esophageal, breast, prostate, and bladder cancers. These tests, though requiring further evaluation for population-wide implementation, represent a promising frontier in cancer research. India needs to develop tailored screening solutions for its diverse and geographically extensive healthcare system. A single centralized screening program cannot effectively serve a nation of 1.4 billion people with such diversity. Instead, a layered approach combining community health workers, digital risk assessment, artificial intelligence, mobile diagnostic services, and strong referral pathways between primary care and cancer centers is needed. Progress is being made with initiatives like the development of a large imaging biobank by NITI Aayog, comprising over 20,000 cancer patient profiles, which can aid in creating AI tools to assist frontline healthcare workers in identifying suspicious lesions. The Draft National Health Research Policy 2026 provides an opportunity to shift from publication-driven research to implementation science, focusing on diseases that contribute most to India's health burden and encouraging research with measurable impact. This approach should promote innovation in affordable screening technologies, risk prediction models, digital health platforms, and implementation research to improve cancer detection across India's diverse healthcare settings. The true measure of success in cancer care should be the number of cancers prevented from reaching advanced stages. Achieving this requires coordinated partnerships between government agencies, medical colleges, technology companies, and community healthcare providers. Dr. Harit K. Chaturvedi, CEO & Clinical Head of Apollo Oncology Network, emphasizes the importance of these coordinated efforts.",
  "summary": "Cancer in India is still diagnosed predominantly after symptoms become severe enough to disrupt daily life. By then, opportunities for curative treatment have often been lost",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}